Decreased DHRS1 expression is a novel predictor of poor survival in patients with hepatocellular carcinoma

Biomark Med. 2021 Oct;15(15):1319-1331. doi: 10.2217/bmm-2021-0041. Epub 2021 Sep 9.

Abstract

Aim: To investigate the effect of aberrant expression of DHRS1 on hepatocellular carcinoma (HCC). Materials & methods: Kaplan-Meier and Cox regression analyses were performed to evaluate the correlation between DHRS1 and overall survival. Gene set enrichment analysis was performed to explore the potential function of DHRS1 in HCC. Results: Multiple data analysis revealed that DHRS1 mRNA and protein expression level were remarkably lower in HCC than that in normal tissues. In survival analysis, patients with low DHRS1 expression presented a poorer prognosis, and was an independent risk factor for HCC. Conclusion: Decreased DHRS1 expression may be a potential predictor of poor prognosis in HCC.

Keywords: DHRS1; HCC; TCGA; prognosis; survival rate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Carcinoma, Hepatocellular / diagnosis
  • Carcinoma, Hepatocellular / genetics*
  • Carcinoma, Hepatocellular / metabolism
  • Female
  • Gene Expression Profiling / methods*
  • Gene Expression Regulation, Neoplastic*
  • Gene Regulatory Networks
  • Humans
  • Kaplan-Meier Estimate
  • Liver Neoplasms / diagnosis
  • Liver Neoplasms / genetics*
  • Liver Neoplasms / metabolism
  • Male
  • Middle Aged
  • Oxidoreductases / genetics*
  • Oxidoreductases / metabolism
  • Prognosis
  • Sensitivity and Specificity
  • Signal Transduction / genetics

Substances

  • DHRS1 protein, human
  • Oxidoreductases